Unaudited operation summary of the group for the third quarter of 2026
Filed with HKEX · Stock code 2666 · · 3 pages · English
Summary by 6ix AI
The report indicates a decrease in consolidated revenue compared to the previous year, while profit for the period showed a slight increase due to improved cost control. The Group's healthcare services experienced growth in outpatient visits and surgical procedures, reflecting advancements in their medical capabilities. The summary also highlights ongoing developments in specialized medical care and healthcare technology, including expansions in nursing care facilities and digital health initiatives.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Genertec Universal Medical Group Company Limited on 6ix
Earlier from Genertec Universal Medical
- Monthly return of equity issuer on movements in securities for the months ended 30 September 2026
- Completion of the public issuance of the corporate bonds (tranche 3) in the PRC by china universal leasing co., ltd., a wholly-owned subsidiary of the company
- 2026 Interim report
- Universal Medical Announces 2023 Interim Results
- Universal Medical (2666.HK) Announces 2022 Annual Results
Later from Genertec Universal Medical
All Genertec Universal Medical news releasesFollow Genertec Universal Medical into a list and get an email when it puts out news.
Follow Genertec Universal Medical